Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegteograstim in Korean Breast Cancer Patients Receiving DD-AC
NCT03575520Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jun 2016
- Primary completion
- Feb 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of pegteograstim in breast cancer, sponsored by Yonsei University. Started Jun 2016; status: completed.
02
Drugs
pegteograstim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03575520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575520.